P-ISSN 2587-2400 | E-ISSN 2587-196X

Ejmo Kapak

EJMO Volume : 7 Issue : 3 Year : 2023

COVID-19 in EJMO 7/3EJMO Current Issue EJMO Archive EJMO & Congress Most Cited Articles Ahead of Print

Copyright Transfer Form

ICMJE COI Form

Ahead of Print

Abstracts of Oncology and immunotherapy association 2019 Congress Abstracts of Oncology and immunotherapy association 2019 Congress doi: 10.14744/ejmo.2019.2019 Abstract \| Full Text PDF \| PDF Download

MiR-19a Mediates Epithelial Mesenchymal Transition of Breast Cancer by Inhibiting KRAS Xianchou Xu, Peinan Wen, Yinghao Wang, Adheesh Bhandari, Riyuan Zhang, Shuqiang Shi, Ouchen Wang doi: 10.14744/ejmo.2021.16863 Abstract

B7-H3 Enhances Colorectal Cancer Progression by Regulating HB-EGF via PI3K-Akt-mTOR-HIF-1a Signaling Chenrui Hu, Shengjia Wang, Xiaokang Ruan, Yonghao Liu, Linwei Wu, Bingxin Chen, Jin Wang, Zhe Zhang, Xin Zhao doi: 10.14744/ejmo.2023.38981 Abstract

Follicular Thyroid Adenoma with Signet Ring Cell Morphology; A Rare Case Report Mehmet Onur Ozturk, Mehmet Celik, Buket Yilmaz Bulbul, Tulin Deniz Yalta, Nuray Can, Semra Ayturk, Sibel Guldiken doi: 10.14744/ejmo.2017.30602 Abstract

A case of thyrotoxic hypochalemic periodic paralysis Yilmaz Inanc, Deniz Tuncel, Mustafa Gokce, Hamza Sahin, Song�l Bavli, Yusuf Inanc doi: 10.14744/ejmo.2017.44154 Abstract

Dysplastic Adenoma in the Choledochal Cyst of an Adult: Biliary Papillomatosis Ramazan Saygin Kerimoglu, Ebru Esen, Emet Ebru Nazik, Umut Ulusoy, Sumeyye Kozacioglu, Osman Dogru doi: 10.14744/ejmo.2017.86580 Abstract

Abstracts of Oncology and immunotherapy association 2018 Congress Abstracts Oncology and immunotherapy association doi: 10.14744/ejmo.2018.2018 Abstract \| Full Text PDF \| PDF Download

ROS1 Rearrangement in Non Small Cell Lung Cancer: Where We are and Where We are going to. Olga Nigro, Alessandro Tuzi, Graziella Pinotti doi: 10.14744/ejmo.2020.42771 Abstract

Submit Manuscript

WEB OF SCIENCE click

Impact Factor: 2.5

Medicine, General & Internal: Q2 146/322

SCOPUS click

CiteScoreTracker 2023: 3.6

CiteScore year 2022:
0.9

CiteScore year 2021:
0.2

Google Scholar click

Number of Articles:315

Citations:2587

h-index:16

i10-index:=26

EJMO NLM ID: 101720527

Accept Ratio :18.2 %

Final decision avg 34 day

Quick Search

�In authors and institutes
�In titles and abstracts
�In keywords
�In all

Copyright � 2023 Eurasian Journal of Medicine and Oncology, EJMO

EJMO & EJMO